Achieving Reductions in Opioid Dispensing: A Qualitative Comparative Analysis of State-Level Efforts to Improve Prescribing

Objective: To determine whether any combinations of state-level public health activities were necessary or sufficient to reduce prescription opioid dispensing. Design: We examined 2016-2019 annual progress reports, 2014-2019 national opioid dispensing data (IQVIA), and interview data from states to categorize activities. We used crisp-set Qualitative Comparative Analysis to determine which program activities, individually or in combination, were necessary or sufficient for a better than average decrease in morphine milligram equivalent (MME) per capita. Setting: Twenty-nine US state health departments. Participants: State health departments implementing the Centers for Disease Control and Prevention's Prevention for States (PfS) program. Main Outcome: Combinations of prevention activities related to changes in the rate of prescription opioid MME per capita dispensing from 2014 to 2019. Results: Three combinations were sufficient for greater than average state-level reductions in MME per capita: (1) expanding and improving proactive reporting in combination with enhancing the uptake of evidence-based opioid prescribing guidelines and not moving toward a real-time Prescription Drug Monitoring Program; (2) implementing or improving prescribing interventions for insurers, health systems, or pharmacy benefit managers in combination with enhancing the uptake of evidence-based opioid prescribing guidelines; and (3) not implementing or improving prescribing interventions for insurers, health systems, or pharmacy benefit managers in combination with not enhancing the uptake of evidence-based opioid prescribing guidelines. Interview data suggested that the 3 combinations indicate how state contexts and history with addressing opioid overdose shaped programming and the ability to reduce MME per capita. Conclusions: States successful in reducing opioid dispensing selected activities that built upon existing policies and interventions, which may indicate thoughtful use of resources. To maximize impact in addressing the opioid overdose epidemic, states and agencies may benefit from building on existing policies and interventions.

[1]  Leonard J. Paulozzi,et al.  Opioid Prescribing Behaviors — Prescription Behavior Surveillance System, 11 States, 2010–2016 , 2020, Morbidity and mortality weekly report. Surveillance summaries.

[2]  Brian E. Whitacre,et al.  Do Prescription Drug Monitoring Programs Encourage Prescription – or Illicit – Opioid Abuse? , 2019, Substance abuse.

[3]  Stephen G. Henry,et al.  Prescription drug monitoring programs operational characteristics and fatal heroin poisoning. , 2019, The International journal on drug policy.

[4]  Yuyan Shi,et al.  The association between pain clinic laws and prescription opioid exposures: New evidence from multi-state comparisons. , 2019, Drug and alcohol dependence.

[5]  M. Asbridge,et al.  The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review , 2019, BMC Health Services Research.

[6]  Tamara M Haegerich,et al.  Evidence for state, community and systems-level prevention strategies to address the opioid crisis , 2019, Drug and alcohol dependence.

[7]  J. Hockenberry,et al.  Prescription Drug Monitoring Program Mandates: Impact On Opioid Prescribing And Related Hospital Use. , 2019, Health affairs.

[8]  Grant T. Baldwin,et al.  Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing. , 2019, Drug and alcohol dependence.

[9]  H. Kunins,et al.  Impact of a prescription drug monitoring program use mandate on potentially problematic patterns of opioid analgesic prescriptions in New York City , 2019, Pharmacoepidemiology and drug safety.

[10]  P. Gruenewald,et al.  Prescription Drug Monitoring Programs and Opioid Overdoses: Exploring Sources of Heterogeneity , 2019, Epidemiology.

[11]  S. Bacon,et al.  From the CDC: The Prevention for States program: Preventing opioid overdose through evidence-based intervention and innovation. , 2019, Journal of safety research.

[12]  Heather Kane,et al.  Qualitative Comparative Analysis in Mixed Methods Research and Evaluation , 2019 .

[13]  M. Buntin,et al.  State laws and policies to reduce opioid-related harm: A qualitative assessment of PDMPs and naloxone programs in ten U.S. States , 2018, Preventive medicine reports.

[14]  María Adela Grando,et al.  Systematic Literature Review of Prescription Drug Monitoring Programs , 2018, AMIA.

[15]  I. Ayres,et al.  The Impact of Prescription Drug Monitoring Programs on U.S. Opioid Prescriptions , 2018, Journal of Law, Medicine & Ethics.

[16]  Likang Xu,et al.  Annual surveillance report of drug-related risks and outcomes -- United States, 2017 , 2017 .

[17]  Donald D. McGeary,et al.  Evaluating the impact of prescription drug monitoring program implementation: a scoping review , 2017, BMC Health Services Research.

[18]  Elizabeth A Stuart,et al.  Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis. , 2016, Drug and alcohol dependence.

[19]  Harold Alan Pincus,et al.  Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians. , 2016, Health affairs.

[20]  R. Chou,et al.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. , 2016, JAMA.

[21]  Grant T Baldwin,et al.  Relationship between Nonmedical Prescription-Opioid Use and Heroin Use. , 2016, The New England journal of medicine.

[22]  Linda Rasubala,et al.  Impact of a Mandatory Prescription Drug Monitoring Program on Prescription of Opioid Analgesics by Dentists , 2015, PloS one.

[23]  Barbara H. Lang,et al.  Prescription Drug Monitoring and Dispensing of Prescription Opioids , 2014, Public health reports.

[24]  Chaim Noy,et al.  Set-theoretic methods for the social sciences: a guide to qualitative comparative analysis , 2013 .

[25]  Bryan J Weiner,et al.  Using organization theory to understand the determinants of effective implementation of worksite health promotion programs. , 2008, Health education research.

[26]  Mark Payne,et al.  Health and Human Services , 2020, Congress and the Nation 2013-2016, Volume XIV: Politics and Policy in the 113th and 114th Congresses.

[27]  Stephen G. Henry,et al.  Measuring relationships between proactive reporting state-level prescription drug monitoring programs and county-level fatal prescription opioid overdoses. , 2019, Epidemiology.

[28]  Carsten Q. Schneider,et al.  SetMethods: an Add-on R Package for Advanced QCA , 2018, R J..